[Can statins slow the process of vascular calcification? Possibilities of lipid-lowering therapy and pleiotropic effect by statin treatment].
Iijima
Katsuya
K
Department of Geriatric Medicine, University of Tokyo.
Ouchi
Yasuyoshi
Y
D050197:Atherosclerosis; D019485:Bone Morphogenetic Proteins; D002114:Calcinosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D050659:Core Binding Factor Alpha 1 Subunit; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000517:prevention & control; D018398:Homeodomain Proteins; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008077:Lipoproteins, LDL; D050380:Monckeberg Medial Calcific Sclerosis; D014652:Vascular Diseases / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*
D019485:Bone Morphogenetic Proteins; D050659:Core Binding Factor Alpha 1 Subunit; D018398:Homeodomain Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; C084119:MSX2 protein; C493709:RUNX2 protein, human; C099252:oxidized low density lipoprotein